Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Mar 29, 2019
Document Date
Mar 29, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/